Supplementary Table 2. Patients characteristics according to lymphadenectomy.
Parameter | No lymphadenectomy (n=89) | Pelvic +/-aortic lymphadenectomy (n=165) | p-value* |
---|---|---|---|
Age (yr) | 0.253 | ||
≤65 | 51 (57.3) | 103 (62.4) | |
>65 | 38 (42.7) | 62 (37.6) | |
Stage | <0.001 | ||
IB | 28 (31.5) | 33 (20.0) | |
II | 33 (37.1) | 40 (24.2) | |
IIIA | 26 (29.2) | 28 (17.0) | |
IIIB | 2 (2.3) | 6 (3.6) | |
IIIC | 0 (0) | 58 (35.2) | |
Myometrial invasion (%) | 0.507 | ||
No | 0 | 0 | |
≤50 | 26 (29.2) | 47 (28.5) | |
>50 | 63 (70.8) | 118 (71.5) | |
Grade | 0.134 | ||
1 and 2 | 37 (41.6) | 82 (49.7) | |
3 | 52 (58.4) | 83 (50.3) | |
LVSI | 0.213 | ||
Negative | 62 (69.7) | 104 (63.8) | |
Positive | 27 (30.3) | 59 (36.2) | |
Adjuvant therapy | 0.224 | ||
No | 20 (22.5) | 35 (21.2) | |
EBRT | 41 (46.1) | 57 (34.6) | |
Chemo | 17 (19.1) | 42 (25.5) | |
Sequential chemo-EBRT | 11 (12.4) | 31 (18.8) |
Values are presented as number (%).
EBRT, external beam radiotherapy; LVSI, lymphovascular space involvement.
*Fisher exact test or Student t-test.